Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL36P12 is a non-protein-coding processed pseudogene belonging to the ribosomal protein L36 gene family[5][6]. Pseudogenes are sequences in the genome that resemble protein-coding genes but are generally considered non-functional due to mutations, truncations, or lack of regulatory elements necessary for protein expression[6]. Like many ribosomal protein genes, the functional RPL36 gene has numerous processed pseudogenes (including RPL36P12) dispersed throughout the genome, created primarily by retrotransposition events[1][3][6]. There is no evidence that RPL36P12 produces a functional protein or plays a role in normal biology or disease. It is not considered a therapeutic target, nor are there known drugs, biomarkers, or disease associations linked to this pseudogene[2][5][6]. If you are seeking information on the functional ribosomal protein, refer to “60S ribosomal protein L36” (gene symbol: RPL36)[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36 pseudogene 12 (RPL36P12).